Market capitalization | $113.64m |
Enterprise Value | $-167.23m |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 2.88 |
EV/Sales (TTM) EV/Sales | -10.85 |
P/S ratio (TTM) P/S ratio | 7.37 |
P/B ratio (TTM) P/B ratio | 0.30 |
Sales growth (TTM) Sales growth | -0.47% |
Turnover (TTM) Turnover | $15.42m |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
3 Analysts have issued a Seer Inc - Ordinary Shares - Class A forecast:
3 Analysts have issued a Seer Inc - Ordinary Shares - Class A forecast:
Mar '24 |
+/-
%
|
||
Turnover | 15 15 |
0%
0%
|
|
Gross income | 1.61 1.61 |
31%
31%
|
|
EBITDA | -96 -96 |
1%
1%
|
EBIT (operating result) EBIT | -101 -101 |
0%
0%
|
Net profit | -83 -83 |
11%
11%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr., and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
Head office | United States |
CEO | Omid Farokhzad |
Employees | 147 |
Founded | 2017 |
Website | www.seer.bio |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.